S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Baker Bros Advisors/Q2 2020

Baker Bros Advisors

Periodo: Q2 2020 Β· Depositato: 2020-08-14
Vedi su SEC EDGAR β†—
AUM
$22.67B
Valore totale del portafoglio
Posizioni
114
Titoli dichiarati
Prima Posizione
SGENXXXX
35.4% $8.03B
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2020-08-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
SGENXXXXSeattle Genetics, Inc.$8.03B35.43%β€”β€”
35.4%
INCYIncyte Corporation$3.33B14.67%$103.97$116.86+12.4%
14.7%
ONCBeiGene, Ltd.$2.22B9.79%$188.40$297.65+58.0%
9.8%
ACADACADIA Pharmaceuticals Inc.$2.03B8.96%$48.47$25.97-46.4%
9.0%
ALXNAlexion Pharmaceuticals, Inc.$983.3M4.34%β€”β€”
4.3%
BMRNBioMarin Pharmaceutical Inc.$936.1M4.13%$123.34$58.99-52.2%
4.1%
KODKodiak Sciences Inc.$626.4M2.76%$54.12$38.54-28.8%
2.8%
ASNDAscendis Pharma A/S$501.4M2.21%$147.90$274.50+85.6%
2.2%
NVTAQInvitae Corporation$359.0M1.58%β€”β€”
1.6%
MYOKMyoKardia, Inc.$305.7M1.35%β€”β€”
1.4%
AMRNXXXXAmarin Corporation plc$238.7M1.05%β€”β€”
1.1%
ARGXargenx SE$229.6M1.01%$225.23$939.68+317.2%
1.0%
IGMSIGM Biosciences, Inc.$229.5M1.01%β€”β€”
1.0%
MDGLMadrigal Pharmaceuticals, Inc.$169.8M0.75%$113.25$528.10+366.3%
0.8%
MRTXMirati Therapeutics, Inc.$161.0M0.71%β€”β€”
0.7%
EXASExact Sciences Corporation$160.5M0.71%β€”β€”
0.7%
NBIXNeurocrine Biosciences, Inc.$110.7M0.49%$122.00$174.26+42.8%
0.5%
PRNBPrincipia Biopharma Inc.$94.5M0.42%β€”β€”
0.4%
FMTXForma Therapeutics Holdings, Inc.$93.0M0.41%β€”β€”
0.4%
CERSCerus Corporation$90.5M0.40%$6.60$3.16-52.1%
0.4%
HRTXHeron Therapeutics, Inc.$88.5M0.39%$14.71$0.44-97.0%
0.4%
INSMInsmed Incorporated$83.3M0.37%$27.54$111.60+305.2%
0.4%
AXSMAxsome Therapeutics, Inc.$83.1M0.37%$82.28$244.31+196.9%
0.4%
ADCTADC Therapeutics SA$79.0M0.35%$46.81$1.19-97.5%
0.3%
BCELAtreca, Inc.$75.2M0.33%β€”β€”
0.3%
KNSAKiniksa Pharmaceuticals, Ltd.$71.3M0.31%$25.48$64.53+153.3%
0.3%
ADAPYAdaptimmune Therapeutics plc$66.8M0.29%$10.01$0.04-99.6%
0.3%
BCRXBioCryst Pharmaceuticals, Inc.$65.6M0.29%$4.76$9.84+106.7%
0.3%
DBVTDBV Technologies S.A.$64.2M0.28%$8.78$15.82+80.2%
0.3%
ZYMEZymeworks Inc.$61.6M0.27%$36.07$26.31-27.1%
0.3%

AttivitΓ  Trimestre su Trimestre

Q2 2020 vs. Q1 2020

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
FMTXForma Therapeutics Holdings, Inc.$93.0M
ADCTADC Therapeutics SA$79.0M-97.5%
ALTAltimmune, Inc.$22.6M
NVAXNovavax, Inc.$20.1M
VXRTVaxart, Inc.$14.5M
XENEXenon Pharmaceuticals Inc.$10.0M
BNRBurning Rock Biotech Limited$6.8M
TARAProtara Therapeutics, Inc.$5.8M

Posizioni Chiuse (8)

TickerEmittenteNozionale
RARXRa Pharmaceuticals, Inc.$100.5M
URGNUroGen Pharma Ltd.$12.0M
BDSIBioDelivery Sciences International, Inc.$6.2M
TARAArTara Therapeutics, Inc.$4.6M
MLNDMillendo Therapeutics, Inc.$4.4M
NERVXXXXMinerva Neurosciences, Inc.$4.1M
HARPXXXXHarpoon Therapeutics, Inc.$2.4M
MNLOMenlo Therapeutics Inc.$1.7M

Aumentate (8)

TickerEmittenteNozionaleVar. Azioni
BLUEXXXXbluebird bio, Inc.$14.3M+562.5%
OVIDOvid Therapeutics Inc.$3.2M+559.6%
AUTLAutolus Therapeutics plc$6.8M+209.8%
AGLEAeglea BioTherapeutics, Inc.$32.5M+155.6%
EVFMEvofem Biosciences, Inc.$0.7M+129.4%
ANABAnaptysBio, Inc.$8.2M+119.0%
KRTXKaruna Therapeutics, Inc.$6.1M+95.3%
CRNXCrinetics Pharmaceuticals, Inc.$3.0M+81.6%

Ridotte (8)

TickerEmittenteNozionaleVar. Azioni
MRKRMarker Therapeutics, Inc.$-2.3M-83.6%
TCDAQTricida, Inc.$-37.0M-70.5%
CPRXCatalyst Pharmaceuticals, Inc.$-1.8M-52.9%
NGMNGM Biopharmaceuticals, Inc.$-0.6M-50.2%
GWPHGW Pharmaceuticals plc$-9.8M-50.1%
ARAVAravive, Inc.$0.0M-49.8%
MTNBMatinas BioPharma Holdings, Inc.$-0.6M-44.2%
IFRXInflarx N.V.$-1.9M-40.5%
← Torna agli Hedge Fund